Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma.

Authors: Dong, Xuesi; Zhang, Ruyang; He, Jieyu; Lai, Linjing; Alolga, Raphael N; Shen, Sipeng; Zhu, Ying; You, Dongfang; Lin, Lijuan; Chen, Chao; Zhao, Yang; Duan, Weiwei; Su, Li; Shafer, Andrea; Salama, Moran; Fleischer, Thomas; Bjaanæs, Maria Moksnes; Karlsson, Anna; Planck, Maria; Wang, Rui; Staaf, Johan; Helland, Åslaug; Esteller, Manel; Wei, Yongyue; Chen, Feng; Christiani, David C

Published In Aging (Albany NY), (2019 Aug 21)

Abstract: Limited studies have focused on developing prognostic models with trans-omics biomarkers for early-stage lung adenocarcinoma (LUAD). We performed integrative analysis of clinical information, DNA methylation, and gene expression data using 825 early-stage LUAD patients from 5 cohorts. Ranger algorithm was used to screen prognosis-associated biomarkers, which were confirmed with a validation phase. Clinical and biomarker information was fused using an iCluster plus algorithm, which significantly distinguished patients into high- and low-mortality risk groups (Pdiscovery = 0.01 and Pvalidation = 2.71×10-3). Further, potential functional DNA methylation-gene expression-overall survival pathways were evaluated by causal mediation analysis. The effect of DNA methylation level on LUAD survival was significantly mediated through gene expression level. By adding DNA methylation and gene expression biomarkers to a model of only clinical data, the AUCs of the trans-omics model improved by 18.3% (to 87.2%) and 16.4% (to 85.3%) in discovery and validation phases, respectively. Further, concordance index of the nomogram was 0.81 and 0.77 in discovery and validation phases, respectively. Based on systematic review of published literatures, our model was superior to all existing models for early-stage LUAD. In summary, our trans-omics model may help physicians accurately identify patients with high mortality risk.

PubMed ID: 31434796 Exiting the NIEHS site

MeSH Terms: Adenocarcinoma of Lung/genetics; Adenocarcinoma of Lung/metabolism*; Aged; Biomarkers, Tumor*; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms/metabolism*; Lung Neoplasms/pathology; Male; Middle Aged; Prognosis*

Back
to Top